These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
220 related items for PubMed ID: 11477473
1. Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction. González P, Alvarez R, Batalla A, Reguero JR, Alvarez V, Astudillo A, Cubero GI, Cortina A, Coto E. Genes Immun; 2001 Jun; 2(4):191-5. PubMed ID: 11477473 [Abstract] [Full Text] [Related]
2. Genetic variation at the CCR5/CCR2 gene cluster and risk of psoriasis and psoriatic arthritis. Soto-Sánchez J, Santos-Juanes J, Coto-Segura P, Coto E, Díaz M, Rodríguez I, Alvarez V. Cytokine; 2010 May; 50(2):114-6. PubMed ID: 20153665 [Abstract] [Full Text] [Related]
3. Genetic variations in CC chemokine receptors and hypertension. Zhang M, Ardlie K, Wacholder S, Welch R, Chanock S, O'Brien TR. Am J Hypertens; 2006 Jan; 19(1):67-72. PubMed ID: 16461193 [Abstract] [Full Text] [Related]
4. Genetic polymorphism of chemokine receptors CCR2 and CCR5 in Swedish cervical cancer patients. Zheng B, Wiklund F, Gharizadeh B, Sadat M, Gambelunghe G, Hallmans G, Dillner J, Wallin KL, Ghaderi M. Anticancer Res; 2006 Jan; 26(5B):3669-74. PubMed ID: 17094383 [Abstract] [Full Text] [Related]
5. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population]. Wasik TJ, Smoleń J, Kruszyński P, Bratosiewicz-Wasik J, Beniowski M. Wiad Lek; 2005 Jan; 58(9-10):500-7. PubMed ID: 16529059 [Abstract] [Full Text] [Related]
6. The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer. Kucukgergin C, Isman FK, Dasdemir S, Cakmakoglu B, Sanli O, Gokkusu C, Seckin S. Gene; 2012 Dec 10; 511(1):7-11. PubMed ID: 22982413 [Abstract] [Full Text] [Related]
7. 5-Hydroxytryptamine 5-HT2A receptor and 5-hydroxytryptamine transporter polymorphisms in acute myocardial infarction. Coto E, Reguero JR, Alvarez V, Morales B, Batalla A, González P, Martín M, García-Castro M, Iglesias-Cubero G, Cortina A. Clin Sci (Lond); 2003 Mar 10; 104(3):241-5. PubMed ID: 12605580 [Abstract] [Full Text] [Related]
8. Polymorphisms in the CC-chemokine receptor-2 (CCR2) and -5 (CCR5) genes and risk of myocardial infarction among Tunisian male patients. Kallel A, Abdessalem S, Sédiri Y, Mourali MS, Feki M, Mechmeche R, Jemaa R, Kaabachi N. Clin Biochem; 2012 Apr 10; 45(6):420-4. PubMed ID: 22285384 [Abstract] [Full Text] [Related]
9. Genotypes and polymorphisms of mutant CCR5-delta 32, CCR2-64I and SDF1-3' a HIV-1 resistance alleles in indigenous Han Chinese. Wang F, Jin L, Lei Z, Shi H, Hong W, Xu D, Jiang J, Wang Y, Zhang B, Liu M, Li Y. Chin Med J (Engl); 2001 Nov 10; 114(11):1162-6. PubMed ID: 11729511 [Abstract] [Full Text] [Related]
10. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis. Kaimen-Maciel DR, Reiche EM, Brum Souza DG, Frota Comini ER, Bobroff F, Morimoto HK, Ehara Watanabe MA, Carvalho De Oliveira J, Matsuo T, Lopes J, Donadi EA. Int J Mol Med; 2007 Sep 10; 20(3):337-44. PubMed ID: 17671738 [Abstract] [Full Text] [Related]
11. Genotypes of CCR2 and CCR5 chemokine receptors in human myasthenia gravis. Zhao X, Gharizadeh B, Hjelmström P, Pirskanen R, Nyrén P, Lefvert AK, Ghaderi M. Int J Mol Med; 2003 Nov 10; 12(5):749-53. PubMed ID: 14533004 [Abstract] [Full Text] [Related]
12. Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer's and Parkinson's disease. Huerta C, Alvarez V, Mata IF, Coto E, Ribacoba R, Martínez C, Blázquez M, Guisasola LM, Salvador C, Lahoz CH, Peña J. Neurosci Lett; 2004 Nov 11; 370(2-3):151-4. PubMed ID: 15488313 [Abstract] [Full Text] [Related]
13. Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder. Vázquez-Lavista LG, Lima G, Gabilondo F, Llorente L. Urology; 2009 Aug 11; 74(2):414-8. PubMed ID: 19646633 [Abstract] [Full Text] [Related]
14. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population. Apostolakis S, Baritaki S, Krambovitis E, Spandidos DA. J Clin Virol; 2005 Dec 11; 34(4):310-4. PubMed ID: 16286055 [Abstract] [Full Text] [Related]
15. Analysis of CCR5-Delta 32 and CCR2-V64I polymorphisms in a cohort of Spanish HCV patients using real-time polymerase chain reaction and fluorescence resonance energy transfer technologies. Ruiz-Ferrer M, Barroso N, Antiñolo G, Aguilar-Reina J. J Viral Hepat; 2004 Jul 11; 11(4):319-23. PubMed ID: 15230854 [Abstract] [Full Text] [Related]
16. Chemokine receptor CCR2/CCR5 polymorphism in Spanish patients with systemic lupus erythematosus. Aguilar F, Núñez-Roldán A, Torres B, Wichmann I, Sánchez-Román J, González-Escribano MF. J Rheumatol; 2003 Aug 11; 30(8):1770-4. PubMed ID: 12913933 [Abstract] [Full Text] [Related]
17. Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection. Mulherin SA, O'Brien TR, Ioannidis JP, Goedert JJ, Buchbinder SP, Coutinho RA, Jamieson BD, Meyer L, Michael NL, Pantaleo G, Rizzardi GP, Schuitemaker H, Sheppard HW, Theodorou ID, Vlahov D, Rosenberg PS, International Meta-Analysis of HIV Host Genetics. AIDS; 2003 Feb 14; 17(3):377-87. PubMed ID: 12556692 [Abstract] [Full Text] [Related]
18. [Distribution of HIV resistance CCR5-delta 32, CCR2-64 I and SDF1-3'A alleles and their polymorphisms in the Han population in China]. Wang F, Jin L, Lei Z, Shi H, Hong W, Xu D, Shi M, Jiang J, Wang Y, Zhang B, Liu M, Li Y. Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Aug 14; 21(4):256-60. PubMed ID: 11860793 [Abstract] [Full Text] [Related]
19. Impact of chemokine receptor CCR2 and CCR5 gene polymorphism on allograft outcome in North Indian renal transplant recipients. Singh R, Kapoor R, Srivastava A, Mittal RD. Scand J Immunol; 2009 Jan 14; 69(1):51-6. PubMed ID: 19037908 [Abstract] [Full Text] [Related]
20. Association of highly active antiretroviral therapy failure with chemokine receptor 5 wild type. Bogner JR, Lutz B, Klein HG, Pollerer C, Troendle U, Goebel FD. HIV Med; 2004 Jul 14; 5(4):264-72. PubMed ID: 15236615 [Abstract] [Full Text] [Related] Page: [Next] [New Search]